ASG Eye Hospital Eyes USD 600 Million IPO Amid Expansion

ASG Eye Hospital is planning to raise USD 500-600 million through an IPO, valuing the company at USD 3.4 billion, with approximately 15% equity dilution. Backed by General Atlantic, ASG aims to expand with a capital expenditure of Rs 2,000 crore by 2030, growing to 500-700 centers.

ASG Eye Hospital, supported by private equity giant General Atlantic, is on track to enter the capital markets through an IPO projected to raise USD 500-600 million—equating to about Rs 3,900 crore, according to insiders familiar with the situation.

The hospital has engaged several investment banks, including Axis Capital, Morgan Stanley, Nomura, Motilal Oswal, and HSBC, for the transaction, expecting a company valuation of about USD 3.4 billion. This move would lead to roughly 15% equity dilution.

The expansion aligns with increasing demands in India's eye-care sector, as ASG plans Rs 2,000 crore in capex by 2030, aiming for 500 to 700 centers through organic growth and acquisitions, capitalizing on regional players like Sharp Sight to strengthen market presence.

(With inputs from agencies.)